Total planned funding: $126,879,220
Allocations
Countries/Regions
Ukraine | $126,879,220 |
Organizational Types
Unknown | $36,993,032 |
Private Contractor | $29,028,578 |
NGO | $19,707,328 |
Own Agency | $15,175,562 |
Multi-lateral Agency | $10,138,586 |
Implementing Agency | $5,497,040 |
Other USG Agency | $4,589,094 |
University | $4,150,000 |
Host Country Government Agency | $1,600,000 |
Program Areas
Governance and Systems | $56,057,698 |
Treatment | $22,102,678 |
Prevention | $17,773,293 |
Management and Operations | $11,765,740 |
Care | $9,702,282 |
Testing | $9,477,529 |
Budget Codes
OHSS: Health Systems Strengthening | $30,670,833 |
HVSI: Strategic Information | $14,141,601 |
HVMS: Management and Operations | $11,765,740 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HLAB: Laboratory Infrastructure | $11,245,264 |
HTXS: Treatment: Adult Treatment | $10,697,388 |
HVCT: Testing: HIV Testing and Counseling | $9,477,529 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $9,147,216 |
HVTB: Care: TB/HIV | $5,906,813 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,235,388 |
HMBL: Biomedical Prevention: Blood Safety | $2,942,932 |
HKID: Care: Orphans and Vulnerable Children | $2,209,128 |
HBHC: Care: Adult Care and Support | $1,586,341 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $154,400 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$36,993,032
Countries/Regions
Chemonics International:
$16,839,470
Countries/Regions
USG Aggregated Agencies:
$14,360,562
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions